Mark M. Jones

185 papers receiving 4.7k citations

Mark M. Jones's Hit Papers

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study 2019 · 703 citations
7030+3+7Years since publication200400600

Peers

Mark M. Jones
Comparison fields: 5 of 180
  • Biological Psychiatry 263
  • Genetics 1.0k
  • Hematology 769
  • Health, Toxicology and Mutagenesis 756
  • Nutrition and Dietetics 540
Replace Roberta J. Ward with:
Roberta J. Ward United Kingdom
John A. Lawson United States
Thomas A. Kent United States
Anthony R. White Australia
Richard A. Cohen United States
Gareth Williams United Kingdom
Quentin R. Smith United States
Alan Davison United Kingdom
Charles R. Scriver Canada
Dominic J. Hare Australia
Mark M. Jones relative to Roberta J. Ward United Kingdom Roberta J. Ward's profile →
Citations per field
00.5×1.5×1.9×
Roberta J. Ward · 1×
Citations per year

Countries citing papers authored by Mark M. Jones

Since Specialization
Citations

This map shows the geographic impact of Mark M. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Jones more than expected).

Fields of papers citing papers by Mark M. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark M. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Jones. The network helps show where Mark M. Jones may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark M. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark M. Jones Line = papers co-authored together Mark M. Jones links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 193 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Hit paper breakdown →
2019703
2
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
Hit paper breakdown →
2015594
3
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
Hit paper breakdown →
2016350
4 2008215
5 2006181
6 2008132
7 2006121
8 2008103
9 2018102
10 199279
11 195978
12 200768
13 201666
14 199565
15 201757
16 198056
17 198949
18 196347
19
Ligand reactivity and catalysis
196842
20 198342

About Mark M. Jones

Mark M. Jones is a scholar working on Health, Toxicology and Mutagenesis, Nutrition and Dietetics, Organic Chemistry, Molecular Biology and Oncology, having authored 193 papers that have together received 4.9k indexed citations. Recurring topics across this work include Heavy Metal Exposure and Toxicity (53 papers), Trace Elements in Health (39 papers), Acute Myeloid Leukemia Research (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Mercury impact and mitigation studies (13 papers), Heavy metals in environment (12 papers), Aluminum toxicity and tolerance in plants and animals (10 papers) and Chemical Thermodynamics and Molecular Structure (9 papers). The work is most often cited by research in Biological Psychiatry (263 citations), Genetics (1.0k citations), Hematology (769 citations), Health, Toxicology and Mutagenesis (756 citations) and Nutrition and Dietetics (540 citations). Mark M. Jones has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include James Blair, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Karina S. Blair, Claire Harrison, Mark A. Basinger, Alayne B. Smith, Shirley G. Jones, Glen R. Gale and Pramod K. Singh. Their work appears in journals such as Journal of the American Chemical Society, Journal of Toxicology and Environmental Health, Blood, Inorganic Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact